drugset / Trial / NCT00178503

Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children

NCT00178503

RandomizedSingle-groupQuadruple-blindTreatment

Summary

This study examined the cognitive and behavioral differences in children who have an autism spectrum disorder (ASD) with or without additional symptoms of ADHD. The study also examined the effectiveness of a range of doses of methylphenidate in improving cognitive and behavioral outcomes in children with both ASD and ADHD.

Timeline

Start
2005-09
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule 2.5 mg
Comparator Methylphenidate Small molecule 5 mg
Comparator Methylphenidate Small molecule 10 mg
Comparator Methylphenidate Small molecule 20 mg
Comparator Methylphenidate Small molecule 30 mg
Comparator Methylphenidate Small molecule 40 mg